Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
Reset 

US Digestive Health and UnitedHealthcare Reach In-Network Coverage Agreement

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  CURE: Digestive Diseases Research Center | Digestive Care, Inc. | National Institute of Diabetes and Digestive and Kidney Diseases | United Digestive

Spectral MD Awarded BARDA Project BioShield Contract Valued at $149 Million for AI-Driven DeepView® Burn Wound Imaging Technology

Read more ››
By: GlobeNewswire - 28 Sep 2023

Syneos Health Closes Transaction with Private Investment Firms

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Syneos Health, Inc

Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Amicus Therapeutics, Inc.

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Sharps Technology, Inc.

AI Therapeutics Announces Name Change to OrphAI Therapeutics

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  OrphAI Therapeutics

VIRBAC: current operating income before R&D slightly improving throughout first half of 2023 in percentage of revenue

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Virbac SA

Vyant Bio Announces Adjournment of Special Meeting of Stockholders

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Vyant Bio, Inc.

NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  NeuroMetrix, Inc.

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  BioNTech SE

ARTHEx Biotech to Present at Chardan's 7th Annual Genetic Medicines Conference

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Arthex Biotech S.L

Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Mabwell Therapeutics, Inc. | Mabwell Biotech Co.,Ltd.

ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  ALR Technologies Inc

SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  HitGen Inc.

Origin Agritech Limited Partners with Strategic Investor Relations, LLC to Support its Corporate Communications and Investor Relations Efforts

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Origin Agritech Limited

WillowTree Transforms Vocable AAC Mobile App with Conversational AI Integration, Giving Voice to Millions

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Armis Biopharma, Inc.

Discovery Behavioral Health Launches First-of-its-kind AI Platform with Videra Health and Leading Research Hospital to Address the "One Year Recovery Gap"

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities Conference

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 Combination Clinical Trial with Motixafortide in First-Line Pancreatic Cancer (PDAC)

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑